EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity

Jiajie Chen, Simiao Fei, Zhihao Cao, Xinchun Liu, Weizhi Ji, Hangrong Chen, Yuyu Niu, Zebin Yang iD

Small · 2025

DOI: 10.1002/smll.202509685 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2025. Verfasst von Jiajie Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunmi…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nanomedicine, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 310 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Fundamental Research Projects, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming within the tumor microenvironment (TME) sustains tumor cell survival, suppresses immune cell functionality, and drives immunosuppression, thereby impairing immunotherapeutic effectiveness and exacerbates clinical challenges. Encouragingly, advances in nanomedicine offer promising strategies to precisely and effectively remodel TME metabolism, including glycolysis, amino acid metabolism, lipid metabolism, etc., to potentiate anti‐tumor immunity. This review delineates distinctive metabolic pathways in tumor cells, immune cells, and cancer stem cells (CSCs) within the immunosuppressive niches, detailing the rational design of nanomedicines with TME metabolism‐modulating capabilities to enhance cancer immunotherapy while elucidating the concrete action mechanisms between nano‐enabled metabolic modulation and immune response activation. Despite the promise, the pivotal challenges listed at the end demand resolution to advance TME metabolism‐modulating nanotherapeutics for meeting personalized clinical anti‐tumor demands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNanomedicineNeoplasmsHumansImmunotherapyAnimals

Stichwörter der Autor:innen

cancer immunotherapyimmunosuppressionmetabolic modulationnanomedicinetumor microenvironment

Autor:innen und Institutionen

  • State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, 650500, China.
  • State key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China.
  • Inorganic Chemistry I, Technische Universität Dresden, Bergstrasse 66, 01069, Dresden, Germany.
  • Yunnan Key Laboratory of Primate Biomedical Research, Kunming, Yunnan, 650500, China.
  • Southwest United Graduate School, Kunming, Yunnan, 650092, China.

ORCID-Profile: Zebin Yang

Förderung

  • National Natural Science Foundation of China
  • Yunnan Fundamental Research Projects
  • China Postdoctoral Science Foundation
  • Shanghai Rising-Star Project (Sailing Program)
  • Shanghai Postdoctoral Excellence Program

Zitieren

APA

Chen, J., Fei, S., Cao, Z., Liu, X., Ji, W., Chen, H., Niu, Y., & Yang, Z. (2025). Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity. Small. https://doi.org/10.1002/smll.202509685

Vancouver

Chen J, Fei S, Cao Z, Liu X, Ji W, Chen H, et al. Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity. Small. 2025. doi:10.1002/smll.202509685

BibTeX
@article{Chen2025,
  author = {Chen, Jiajie and Fei, Simiao and Cao, Zhihao and Liu, Xinchun and Ji, Weizhi and Chen, Hangrong and Niu, Yuyu and Yang, Zebin},
  title = {Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202509685}
}
Kostenlos starten →